Skip to main content
Year archive

DongKoo Bio & Pharma Co., Ltd. — 2026 filings

All 15 regulatory filings released by DongKoo Bio & Pharma Co., Ltd. (006620) in 2026, sourced directly from the official regulator.

15 Filings
2026 Period
2026 filings (15)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-04-02 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-04-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-23 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-16 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-16 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2026-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2025
2026-03-16 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-01-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-01-12 Korean